These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2561831)

  • 1. Behavioral pharmacology of PCP, NMDA and sigma receptors.
    Balster RL
    NIDA Res Monogr; 1989; 95():270-4. PubMed ID: 2561831
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands.
    Sircar R; Samaan H; Nichtenhauser R; Snell LD; Johnson KM; Rivier J; Vale W; Zukin RS; Zukin SR
    NIDA Res Monogr; 1986; 75():157-60. PubMed ID: 2828962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of PCP, NMDA and opiate receptors.
    Wilkins J
    NIDA Res Monogr; 1989; 95():275-81. PubMed ID: 2577034
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adaptive changes in sigma and phencyclidine receptors during the long-term use of haloperidol and raclopride in rats].
    Vasar EE; Lang AE; Kharro IaE; Allikmets LKh
    Biull Eksp Biol Med; 1989 Sep; 108(9):306-9. PubMed ID: 2558744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phencyclidine-like drugs on punished behavior in rats.
    Porter JH; Wiley JL; Balster RL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):997-1002. PubMed ID: 2539469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays.
    Contreras PC; Quirion R; O'Donohue TL
    NIDA Res Monogr; 1986; 64():80-93. PubMed ID: 3012347
    [No Abstract]   [Full Text] [Related]  

  • 8. Phencyclidine receptors and N-methyl-D-aspartate antagonism: electrophysiologic data correlates with known behaviours.
    Martin D; Lodge D
    Pharmacol Biochem Behav; 1988 Oct; 31(2):279-86. PubMed ID: 2854262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral pathways activated by PCP-like compounds: relevance to neurotransmitters and their receptors.
    Piercey MF; Hoffmann WE
    NIDA Res Monogr; 1989; 95():264-9. PubMed ID: 2577033
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid.
    Javitt DC; Jotkowitz A; Sircar R; Zukin SR
    Neurosci Lett; 1987 Jul; 78(2):193-8. PubMed ID: 2888059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
    Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research.
    Zukin SR; Javitt DC
    NIDA Res Monogr; 1989; 95():247-54. PubMed ID: 2561829
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
    Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
    Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
    Goldberg MP; Viseskul V; Choi DW
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid method for evaluating the behavioral effects of phencyclidine-like dissociative anesthetics in mice.
    Evoniuk GE; Hertzman RP; Skolnick P
    Psychopharmacology (Berl); 1991; 105(1):125-8. PubMed ID: 1660607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
    Kushner L; Zukin SR; Zukin RS
    Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and behavioral effects of sigma and PCP ligands.
    Contreras PC; Contreras ML; O'Donohue TL; Lair CC
    Synapse; 1988; 2(3):240-3. PubMed ID: 2850629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs acting on sigma and phencyclidine receptors: a review of their nature, function, and possible therapeutic importance.
    Junien JL; Leonard BE
    Clin Neuropharmacol; 1989 Oct; 12(5):353-74. PubMed ID: 2558790
    [No Abstract]   [Full Text] [Related]  

  • 20. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.